Dasatinib: ten years of clinical practice worldwide
The article contains results of meta-analysis of experience in use of second-generation tyrosine kinase inhibitors – dasatinib. The results of clinical trials dasatinib therapy in chronic myelogenous leukemia imatinib-resistant or intolerant patients are presented. The dasatinib and imatinib compara...
Saved in:
| Main Authors: | K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-03-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
by: V. A. Shuvaev, et al.
Published: (2014-07-01) -
Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01) -
Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study
by: Ana Maria Meireles, et al.
Published: (2025-07-01) -
Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review
by: Liqing Yang, et al.
Published: (2025-07-01) -
Chronic myeloid leukemia in childhood: a case report
by: Uma Bhatta, et al.
Published: (2021-09-01)